• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[室性心动过速。诊断范围及治疗措施]

[Ventricular tachycardia. Diagnostic spectrum and therapeutic measures].

作者信息

Lewalter T, Schwab J O, Nickenig G

机构信息

Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Strasse 25, 53105, Bonn, Germany.

出版信息

Internist (Berl). 2006 Oct;47(10):1001-4, 1006-8, 1010-2. doi: 10.1007/s00108-006-1708-6.

DOI:10.1007/s00108-006-1708-6
PMID:16969671
Abstract

The origin of ventricular tachycardia lies in the ventricular tissue and includes a variety of symptoms such as monomorphic and polymorphic ventricular tachyarrhythmia (VT), ventricular flutter and ventricular fibrillation. Due to transitions of one form of VT to another, any form of VT incurs in principal the risk of cardiac failure. Apart from different electrophysiologic mechanisms such as reentry or triggered activity, any occurrence of VT has to be considered in an individual context: VT can be caused by structural heart disease such as coronary artery disease or dilative cardiomyopathy, or primary electrical disease such as long or short QT syndromes or can even occur without any detectable cause (idiopathic VT). Correct identification of the underlying cause of the arrhythmia is essential for the prognosis, differential therapy and long-term treatment of patients.

摘要

室性心动过速起源于心室组织,包括多种症状,如单形性和多形性室性快速心律失常(VT)、心室扑动和心室颤动。由于一种VT形式可转变为另一种形式,任何形式的VT都主要存在心力衰竭风险。除了折返或触发活动等不同的电生理机制外,任何VT的发生都必须在个体背景下考虑:VT可由结构性心脏病如冠状动脉疾病或扩张型心肌病引起,或由原发性电疾病如长QT综合征或短QT综合征引起,甚至可在无任何可检测到的病因(特发性VT)的情况下发生。正确识别心律失常的潜在病因对于患者的预后、鉴别治疗和长期治疗至关重要。

相似文献

1
[Ventricular tachycardia. Diagnostic spectrum and therapeutic measures].[室性心动过速。诊断范围及治疗措施]
Internist (Berl). 2006 Oct;47(10):1001-4, 1006-8, 1010-2. doi: 10.1007/s00108-006-1708-6.
2
Sustained ventricular tachycardia in structural heart disease.结构性心脏病中的持续性室性心动过速。
Cardiol J. 2015;22(1):12-24. doi: 10.5603/CJ.a2014.0069. Epub 2014 Oct 9.
3
Ventricular tachycardia and sudden cardiac death.室性心动过速与心源性猝死。
Mayo Clin Proc. 2009 Mar;84(3):289-97. doi: 10.4065/84.3.289.
4
Clinical management of ventricular tachycardia.室性心动过速的临床处理。
Curr Probl Cardiol. 2010 Sep;35(9):453-504. doi: 10.1016/j.cpcardiol.2010.08.001.
5
Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.在非缺血性扩张型心肌病中,心肌瘢痕可预测单形性室性心动过速,但不能预测多形性室性心动过速或心室颤动。
Heart Rhythm. 2015 Oct;12(10):2106-14. doi: 10.1016/j.hrthm.2015.05.026. Epub 2015 May 22.
6
Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.致心律失常性右心室发育不良/心肌病中的室性心动过速:临床表现、危险分层及长期随访结果
Int J Cardiol. 2006 Mar 8;107(3):360-8. doi: 10.1016/j.ijcard.2005.03.049.
7
Non-pharmacological management of ventricular tachycardia.非药物治疗室性心动过速。
Circ J. 2007;71 Suppl A:A97-105. doi: 10.1253/circj.71.a97.
8
[Indications for catheter ablation of ventricular tachycardia].[室性心动过速导管消融的适应证]
Dtsch Med Wochenschr. 2013 Sep;138(39):1952-6. doi: 10.1055/s-0033-1349563. Epub 2013 Sep 17.
9
Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease.先天性心脏病修复术后成人室性心动过速导管消融的机制与结果
Heart Rhythm. 2016 Jul;13(7):1449-54. doi: 10.1016/j.hrthm.2016.03.002. Epub 2016 Mar 4.
10
[Ventricular tachycardia--etiology, mechanisms and therapy].[室性心动过速——病因、机制与治疗]
Ther Umsch. 2004 Apr;61(4):257-64. doi: 10.1024/0040-5930.61.4.257.

引用本文的文献

1
Surgical therapy of ventricular arrhythmias.室性心律失常的外科治疗
Herzschrittmacherther Elektrophysiol. 2007 Jun;18(2):62-7. doi: 10.1007/s00399-007-0561-1.

本文引用的文献

1
Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias.心脏兰尼碱受体的稳定作用可防止细胞内钙泄漏和心律失常。
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7906-10. doi: 10.1073/pnas.0602133103. Epub 2006 May 3.
2
Exercise-induced ventricular arrhythmias in patients with no structural cardiac disease.无结构性心脏病患者运动诱发的室性心律失常
Annu Rev Med. 2006;57:473-84. doi: 10.1146/annurev.med.57.081704.090151.
3
Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.
β受体阻滞剂、胺碘酮联合β受体阻滞剂或索他洛尔预防植入式心律转复除颤器电击的比较:OPTIC研究:一项随机试验。
JAMA. 2006 Jan 11;295(2):165-71. doi: 10.1001/jama.295.2.165.
4
Genomics and cardiac arrhythmias.基因组学与心律失常
J Am Coll Cardiol. 2006 Jan 3;47(1):9-21. doi: 10.1016/j.jacc.2005.08.059. Epub 2005 Dec 15.
5
[Right ventricular tachyarrhythmias--diagnostics and therapy].[右室性快速心律失常——诊断与治疗]
Herzschrittmacherther Elektrophysiol. 2005 Dec;16(4):260-9. doi: 10.1007/s00399-005-0493-6.
6
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.氟卡尼在长QT-3综合征(DeltaKPQ突变)患者中的安全性和有效性:一项随机、双盲、安慰剂对照临床试验。
Ann Noninvasive Electrocardiol. 2005 Oct;10(4 Suppl):59-66. doi: 10.1111/j.1542-474X.2005.00077.x.
7
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.植入式心脏复律除颤器患者使用的抗心律失常药物。
Am J Cardiovasc Drugs. 2005;5(6):371-8. doi: 10.2165/00129784-200505060-00004.
8
Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives.特发性右心室流出道心动过速的消融:当前观点
J Cardiovasc Electrophysiol. 2005 Sep;16 Suppl 1:S52-8. doi: 10.1111/j.1540-8167.2005.50163.x.
9
Long QT syndrome: from channels to cardiac arrhythmias.长QT综合征:从离子通道到心律失常
J Clin Invest. 2005 Aug;115(8):2018-24. doi: 10.1172/JCI25537.
10
Brugada syndrome: report of the second consensus conference.布加综合征:第二次共识会议报告
Heart Rhythm. 2005 Apr;2(4):429-40. doi: 10.1016/j.hrthm.2005.01.005.